By Andrea Germanos, staff writer CDC principal deputy director Dr. Anne Schuchat said we’re “not even beginning to be over this.” Dr. Anne Schuchat, principal deputy director of the Centers for Disease Control and Prevention, testifies before the Senate Health, Education, Labor and Pensions Committee during a hearing on “An Emerging Disease Threat: How the...
by University of Virginia Doctors can examine COVID-19 patients’ blood to identify those at greatest risk of severe illness and to pinpoint those most likely to need a ventilator, new research from the University of Virginia School of Medicine suggests. The discovery could lead to new treatments to prevent deadly “cytokine storms” seen in severe...
More than 40 percent of people diagnosed with COVID-19 in one Italian town showed no signs of being ill, according to research published Tuesday indicating that asymptomatic carriers may be significant spreaders of the virus. The authors said their research showed how important mass testing and isolating carriers was in containing clusters of the virus....
By Sally Robertson, B.Sc. Researchers in the U.S. have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of coronavirus disease 2019 (COVID-19). The tool, called COVID-KOP, prioritized 73 combinations of 32 drugs as potential treatments for severe acute respiratory syndrome coronavirus...
The COVID-19 pandemic has brought a slew of new challenges for clinical facilities, including how to deliver as much care as possible at a distance. The Department of Cardiovascular Medicine at Tokyo Medical and Dental University (TMDU) Medical Hospital is working with Kyocera to be able to deliver rehab therapy to patients while closely monitoring...
Researchers have shown that a variation in the viral genome of Covid-19 improved its ability to infect human cells and helped it become the dominant strain circulating around the world today. The study, published today in the journal Cell, shows the variation is more infectious in cell cultures under laboratory conditions. The variant, named ‘D614G’,...
by Max Planck Society Erythropoietin (Epo) is actually a medication for anemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth factor could mitigate severe disease progression and protect patients from long-term neurological effects when the SARS-CoV-2 virus attacks...
Steroids may offer vital COVID-19 treatment strategy THE ENDOCRINE SOCIETY WASHINGTON–People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society. “We explored the previous SARS outbreak caused by the very similar virus SARS-CoV-1 to advise endocrinologists involved in...
Designer peptide could become effective in reducing damage caused by COVID-19 infections UNIVERSITY OF TORONTO – FACULTY OF DENTISTRY TORONTO, ON (June 30, 2020) — A collaboration between the University of Toronto’s Faculty of Dentistry and the National Jewish Health in Denver — the top-ranked respiratory research hospital in the U.S. — has yielded a...
by Research Institute of Molecular Pathology It has long been known that the acquired immune system can generate a vast antibody (immunoglobulin) repertoire by gene recombination in developing B-cells. However, it was not understood how the different immunoglobulin gene segments can meet each other in the three-dimensional space of a B-cell nucleus to undergo recombination,...
